308 related articles for article (PubMed ID: 30420849)
1. Drug Resistance in
Montazeri M; Mehrzadi S; Sharif M; Sarvi S; Tanzifi A; Aghayan SA; Daryani A
Front Microbiol; 2018; 9():2587. PubMed ID: 30420849
[No Abstract] [Full Text] [Related]
2. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
[TBL] [Abstract][Full Text] [Related]
3. Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil.
Silva LA; Reis-Cunha JL; Bartholomeu DC; Vítor RW
PLoS One; 2017; 12(1):e0170689. PubMed ID: 28118394
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo susceptibility to sulfadiazine and pyrimethamine of Toxoplasma gondii strains isolated from Brazilian free wild birds.
de Lima Bessa G; Vitor RWA; Lobo LMS; Rêgo WMF; de Souza GCA; Lopes REN; Costa JGL; Martins-Duarte ES
Sci Rep; 2023 May; 13(1):7359. PubMed ID: 37147353
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii in South America: a differentiated pattern of spread, population structure and clinical manifestations.
de Lima Bessa G; de Almeida Vitor RW; Dos Santos Martins-Duarte E
Parasitol Res; 2021 Sep; 120(9):3065-3076. PubMed ID: 34390383
[TBL] [Abstract][Full Text] [Related]
6. Brazilian strains of Toxoplasma gondii are controlled by azithromycin and modulate cytokine production in human placental explants.
Franco PS; Gois PSG; de Araújo TE; da Silva RJ; de Freitas Barbosa B; de Oliveira Gomes A; Ietta F; Dos Santos LA; Dos Santos MC; Mineo JR; Ferro EAV
J Biomed Sci; 2019 Jan; 26(1):10. PubMed ID: 30665403
[TBL] [Abstract][Full Text] [Related]
7. Pathogenicity and phenotypic sulfadiazine resistance of Toxoplasma gondii isolates obtained from livestock in northeastern Brazil.
Oliveira CB; Meurer YS; Andrade JM; Costa ME; Andrade MM; Silva LA; Lanza DC; Vítor RW; Andrade-Neto VF
Mem Inst Oswaldo Cruz; 2016 Jun; 111(6):391-8. PubMed ID: 27276184
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Efficacy of Drugs against Toxoplasma gondii Combined with Immunomodulators.
Köksal ZŞ; Yanik K; Bilgin K; Yılmaz EM; Hokelek M
Jpn J Infect Dis; 2016; 69(2):113-7. PubMed ID: 26166498
[TBL] [Abstract][Full Text] [Related]
9. A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans.
Wei HX; Wei SS; Lindsay DS; Peng HJ
PLoS One; 2015; 10(9):e0138204. PubMed ID: 26394212
[TBL] [Abstract][Full Text] [Related]
10. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
Costa IN; Angeloni MB; Santana LA; Barbosa BF; Silva MC; Rodrigues AA; Rostkowsa C; Magalhães PM; Pena JD; Silva DA; Mineo JR; Ferro EA
Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis.
Aspinall TV; Joynson DH; Guy E; Hyde JE; Sims PF
J Infect Dis; 2002 Jun; 185(11):1637-43. PubMed ID: 12023770
[TBL] [Abstract][Full Text] [Related]
12. A new iron(III) complex-containing sulfadiazine inhibits the proliferation and induces cystogenesis of Toxoplasma gondii.
Portes JA; Azeredo NFB; Siqueira PGT; de Souza TG; Fernandes C; Horn A; Candela DRS; de Souza W; DaMatta RA; Seabra SH
Parasitol Res; 2018 Sep; 117(9):2795-2805. PubMed ID: 29934691
[TBL] [Abstract][Full Text] [Related]
13. Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin.
Pfefferkorn ER; Borotz SE
Antimicrob Agents Chemother; 1994 Jan; 38(1):31-7. PubMed ID: 8141576
[TBL] [Abstract][Full Text] [Related]
14. Azithromycin treatment is able to control the infection by two genotypes of Toxoplasma gondii in human trophoblast BeWo cells.
Ribeiro M; Franco PS; Lopes-Maria JB; Angeloni MB; Barbosa BF; Gomes AO; Castro AS; Silva RJD; Oliveira FC; Milian ICB; Martins-Filho OA; Ietta F; Mineo JR; Ferro EAV
Exp Parasitol; 2017 Oct; 181():111-118. PubMed ID: 28803905
[TBL] [Abstract][Full Text] [Related]
15. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
[TBL] [Abstract][Full Text] [Related]
16. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
[TBL] [Abstract][Full Text] [Related]
17. Induction of sulfadiazine resistance in vitro in Toxoplasma gondii.
Doliwa C; Escotte-Binet S; Aubert D; Velard F; Schmid A; Geers R; Villena I
Exp Parasitol; 2013 Feb; 133(2):131-6. PubMed ID: 23206954
[TBL] [Abstract][Full Text] [Related]
18. Sulfadiazine resistance in Toxoplasma gondii: no involvement of overexpression or polymorphisms in genes of therapeutic targets and ABC transporters.
Doliwa C; Escotte-Binet S; Aubert D; Sauvage V; Velard F; Schmid A; Villena I
Parasite; 2013; 20():19. PubMed ID: 23707894
[TBL] [Abstract][Full Text] [Related]
19. Strain hypothesis of Toxoplasma gondii infection on the outcome of human diseases.
Xiao J; Yolken RH
Acta Physiol (Oxf); 2015 Apr; 213(4):828-45. PubMed ID: 25600911
[TBL] [Abstract][Full Text] [Related]
20. Sulfadiazine Sodium Ameliorates the Metabolomic Perturbation in Mice Infected with Toxoplasma gondii.
Zhou CX; Gan Y; Elsheikha HM; Chen XQ; Cong H; Liu Q; Zhu XQ
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
